Zihang Yuan

469 total citations
29 papers, 378 citations indexed

About

Zihang Yuan is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Zihang Yuan has authored 29 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Zihang Yuan's work include Drug Transport and Resistance Mechanisms (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Natural Compounds in Disease Treatment (6 papers). Zihang Yuan is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Liver Disease Diagnosis and Treatment (7 papers) and Natural Compounds in Disease Treatment (6 papers). Zihang Yuan collaborates with scholars based in China, Pakistan and United States. Zihang Yuan's co-authors include Luyong Zhang, Zhenzhou Jiang, Ziqiao Yuan, Xiaojiaoyang Li, Lixin Sun, Hang Yang, Muhammad Hasnat, Xiaoxin Liu, Runping Liu and Rong Sun and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Ethnopharmacology and Life Sciences.

In The Last Decade

Zihang Yuan

23 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zihang Yuan China 11 136 123 106 95 81 29 378
Yingmei Tang China 10 105 0.8× 127 1.0× 52 0.5× 123 1.3× 41 0.5× 20 352
Haidong Bao China 11 164 1.2× 66 0.5× 35 0.3× 81 0.9× 25 0.3× 16 350
Amal M. H. Ghanim Egypt 10 30 0.2× 60 0.5× 41 0.4× 122 1.3× 27 0.3× 12 316
Yung-Tsung Chiu Taiwan 12 27 0.2× 139 1.1× 80 0.8× 133 1.4× 21 0.3× 20 447
Wen Feng China 12 74 0.5× 26 0.2× 22 0.2× 90 0.9× 47 0.6× 31 316
Baolin Qian China 10 41 0.3× 62 0.5× 44 0.4× 124 1.3× 10 0.1× 34 290
Saori Yamada Japan 10 37 0.3× 117 1.0× 57 0.5× 75 0.8× 17 0.2× 24 396
Nirmeen Megahed Egypt 13 117 0.9× 75 0.6× 19 0.2× 58 0.6× 18 0.2× 26 362
Wenxuan Yu China 11 69 0.5× 42 0.3× 27 0.3× 109 1.1× 16 0.2× 24 304

Countries citing papers authored by Zihang Yuan

Since Specialization
Citations

This map shows the geographic impact of Zihang Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zihang Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zihang Yuan more than expected).

Fields of papers citing papers by Zihang Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zihang Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zihang Yuan. The network helps show where Zihang Yuan may publish in the future.

Co-authorship network of co-authors of Zihang Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Zihang Yuan. A scholar is included among the top collaborators of Zihang Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zihang Yuan. Zihang Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chunlan, et al.. (2025). Insights into the molecular regulatory mechanisms of tumor macropinocytosis. Chinese Science Bulletin (Chinese Version).
2.
Wang, Jie, Zihang Yuan, Haoran Zhang, et al.. (2025). Obeticholic acid exacerbates liver injury through hepatocyte-mediated release of HMGB1 by inducing lysosomal membrane permeabilization in cholestasis. Chemico-Biological Interactions. 421. 111752–111752.
5.
Zhang, Zhonghui, Zihang Yuan, Yiying Wang, et al.. (2024). Upregulation of granzyme B and C-X3-C motif receptor 1 in circulating plasmablasts was negatively regulated by Notch signal in patients with systemic lupus erythematosus. Journal of Leukocyte Biology. 116(5). 1061–1071. 1 indexed citations
6.
Zhao, Ming, Meng Li, Jiaxin Ren, et al.. (2023). Alterations in Helios+ T cell subsets in peripheral blood of early-stage lung adenocarcinoma patients: Implications for early diagnosis. Immunobiology. 228(6). 152749–152749. 1 indexed citations
7.
Liu, Chen, Yiying Wang, Yahui Zhang, et al.. (2023). Elevated Layilin-Positive Monocyte Levels in the Peripheral Blood of Patients with Systemic Lupus Erythematosus Reflect Their Autoimmune Status. Immunological Investigations. 52(7). 879–896.
9.
Yuan, Ziqiao, Ying Zhu, Zihang Yuan, et al.. (2022). Th17/Treg imbalance mediates hepatic intolerance to exogenous lipopolysaccharide and exacerbates liver injury in triptolide induced excessive immune response. Journal of Ethnopharmacology. 295. 115422–115422. 23 indexed citations
10.
Yuan, Zihang, Yumei Zhang, Chris Bishop, et al.. (2022). Optimal velocity loss threshold for inducing post activation potentiation in track and field athletes. Biology of Sport. 40(2). 603–609. 6 indexed citations
11.
Yuan, Zihang, Jie Wang, Yingying Miao, et al.. (2022). Triptolide leads to hepatic intolerance to exogenous lipopolysaccharide and natural-killer-cell mediated hepatocellular damage by inhibiting MHC class I molecules. Phytomedicine. 109. 154621–154621. 10 indexed citations
12.
Miao, Yingying, Qin Zhang, Zihang Yuan, et al.. (2022). Proteomics analysis reveals novel insights into the mechanism of hepatotoxicity induced by Tripterygium wilfordii multiglycoside in mice. Frontiers in Pharmacology. 13. 1032741–1032741. 1 indexed citations
13.
Yuan, Zihang, Jie Wang, Haoran Zhang, et al.. (2022). Triptolide increases resistance to bile duct ligation-induced liver injury and fibrosis in mice by inhibiting RELB. Frontiers in Nutrition. 9. 1032722–1032722. 9 indexed citations
14.
Wang, Jie, Zihang Yuan, Haoran Zhang, et al.. (2022). Obeticholic acid aggravates liver injury by up-regulating the liver expression of osteopontin in obstructive cholestasis. Life Sciences. 307. 120882–120882. 8 indexed citations
15.
Yang, Tingting, Xue Wang, Yi Zhou, et al.. (2021). SEW2871 attenuates ANIT-induced hepatotoxicity by protecting liver barrier function via sphingosine 1-phosphate receptor-1–mediated AMPK signaling pathway. Cell Biology and Toxicology. 37(4). 595–609. 13 indexed citations
16.
Yuan, Ziqiao, Zihang Yuan, Muhammad Hasnat, et al.. (2020). A new perspective of triptolide-associated hepatotoxicity: the relevance of NF- B and NF- B-mediated cellular FLICE-inhibitory protein. Acta Pharmaceutica Sinica B. 10(5). 861–877. 35 indexed citations
17.
Yuan, Ziqiao, Muhammad Hasnat, Zihang Yuan, et al.. (2019). The role of inflammasome activation in Triptolide-induced acute liver toxicity. International Immunopharmacology. 75. 105754–105754. 45 indexed citations
18.
Liu, Xiaoxin, Xiaojiaoyang Li, Zihang Yuan, et al.. (2016). Protective effects of SRT1720 via the HNF1α/FXR signalling pathway and anti-inflammatory mechanisms in mice with estrogen-induced cholestatic liver injury. Toxicology Letters. 264. 1–11. 31 indexed citations
19.
Li, Xiaojiaoyang, Zihang Yuan, Runping Liu, et al.. (2016). UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats. Toxicology and Applied Pharmacology. 311. 12–25. 38 indexed citations
20.
Li, Xiaojiaoyang, Runping Liu, Zihang Yuan, et al.. (2016). Alpha-naphthylisothiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes. Toxicology. 370. 106–115. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026